GSMA
23.9.2020 13:27:09 CEST | Business Wire | Press release
GSMA today announced a rescheduling of its world-class MWC series for 2021. MWC21 Shanghai will now take place from 23 – 25 February 2021, and MWC21 Barcelona will now take place between 28 June – 1 July 2021.
Moving MWC21 Barcelona, initially scheduled for the first week of March 2021, allows the GSMA to contend with external circumstances related to Covid-19.
The GSMA is committed and investing so that MWC21 Barcelona can go ahead safely and offer the unique, unmissable experience that has made it the world’s most important mobile ecosystem convening platform. MWC21 Barcelona will also have virtual elements to complement the overwhelming demand to convene physically.
Mats Granryd, Director General, GSMA said: “With a continuously changing global outlook and following consultation with our board and membership and our top exhibitors, we have taken the careful decision to reschedule MWC21 Shanghai in February, and MWC21 Barcelona in June. The health and safety of our exhibitors, attendees, staff and the people of Barcelona are of paramount importance.”
John Hoffman, CEO GSMA Ltd., said: “We have been overwhelmed by the support of all our partners and clients who remain dedicated to ensuring MWC21 Barcelona is a success. MWC is more than just an event. It’s an experience that brings the whole industry together and provides a platform to unlock the power of connectivity so that people, industry and society thrive.”
The rescheduling respects the global circumstance surrounding Covid-19. It recognises that both events are catalysts in the mobile ecosystem; they are platforms for launching new products and innovations, bringing together decision and deal makers.
The GSMA continues to work closely with the Host City Parties, and the decision to change the date of MWC21 Barcelona follows a period of planning and consultation with all major stakeholders. The date changes also ensure that 2021 reverts to a full annual cycle of MWC events between Shanghai, Barcelona and LA. Both the Host City Parties and the GSMA board support the decision of the GSMA.
Pau Relat, President of Governing board of Fira de Barcelona, said: “We fully support the GSMA’s decision to reschedule the dates for MWC Barcelona and are deeply committed to making the best possible 2021 edition with an extraordinary participation of companies and visitors. The long-standing partnership between the MWC, Fira and the city of Barcelona has been a very successful one for everyone, and I’m sure it will continue to be so in the future.”
Over the balance of 2020, the GSMA remains excited about its virtual series, Thrive, with remaining events in Africa, North America, Asia Pacific, Eurasia and Latin America. For more information, please click here, https://www.gsmathrive.com/ .
- ENDS -
Notes to Editors
Host City Parties include: Barcelona City Council, Generalitat de Catalunya, the Ministry of Industry, Energy and Tourism, Fira de Barcelona, Tourism de Barcelona
About GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with almost 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005487/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corpay Cross-Border Named the Official FX Supplier of Toulouse Football Club23.4.2026 14:30:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Toulouse Football Club to become their Official Foreign Exchange (FX) Supplier. A partnership brought together by SPORTFIVE, an international sports marketing agency. Through this partnership, Corpay Cross-Border will deliver comprehensive FX risk management solutions to support Toulouse Football Club’s operations. In addition, its award-winning platform will enable the club to manage global payments seamlessly through a single point of access. “Corpay Cross-Border is proud to be named the Official FX Supplier of Toulouse Football Club,” said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “This partnership reinforces Corpay’s position as a leading provider of corporate payments and currency risk management solutions within prof
Philip Morris International Expands its Partnership with Ducati Corse as Decades-Long Partnership Races Forward with Purpose23.4.2026 14:00:00 CEST | Press release
ZYN branding to be present at select MotoGP races in the 2026 season and beyond Philip Morris International1 (NYSE: PM) today announced an expanded partnership with Ducati Corse for the 2026 season and beyond. This next chapter introduces a major development: the ZYN brand of nicotine pouches—the number one nicotine pouch brand globally2—will feature on Ducati Corse MotoGP liveries at select races throughout the seasons. Just as Ducati pushes the limits of performance, ZYN represents PMI’s commitment to delivering innovation, offering a product that delivers exceptional quality while being thoughtfully designed. This partnership allows ZYN to connect with adult consumers in a space they’re passionate about—and to do so in a way that’s authentic, respectful, and dynamic. Philip Morris International’s relationship with Ducati Corse began in 2003—the year Ducati arrived in MotoGP—ushering in a bold new era of ambition. Since then, the collaboration has evolved alongside both organizations
Vitrealab and poLight ASA Partner to Tackle Coherence Artifacts in Laser-LCoS AR Displays23.4.2026 14:00:00 CEST | Press release
Vitrealab GmbH and poLight ASA (OSE: PLT) today announced a collaboration to advance laser illumination architectures for LCoS-based augmented reality (AR) displays, with a focus on mitigating coherence-related image artifacts while preserving system efficiency and compactness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423345474/en/ Vitrealab GmbH and poLight ASA (OSE: PLT) today announced a collaboration to advance laser illumination architectures for LCoS-based augmented reality (AR) displays, with a focus on mitigating coherence-related image artifacts while preserving system efficiency and compactness. Vitrealab’s Quantum Light Chip combined with poLight's TWedge® wobulation technology helps create a higher performing and more manufacturable AR system. Laser-based illumination offers clear system-level advantages for LCoS based AR light engines, including high optical efficiency due to intrinsic polarization, imp
GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents23.4.2026 13:29:00 CEST | Press release
Mangaciclanol, if approved, could transform contrast-enhanced MR imaging by offering an alternative to - or even replacing - gadolinium-based MRI agentsA manganese-based MRI contrast agent could address concerns with gadolinium-based contrast agents around retention in the body, security of supply, and the environment, with mangaciclanol’s clinical development under FDA Fast Track designationThe program demonstrates GE HealthCare’s commitment to advancing novel imaging agents to address unmet patient needs GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 LUMINA clinical trial of its manganese-based magnetic resonance imaging (MRI) contrast agent, mangaciclanol, at Mayo Clinic in Rochester, Minnesota. Mangaciclanol, if approved, could offer an alternative to – or even replace – gadolinium-based MRI contrast agents, the current standard of care. The investigational agent has been granted Fast Track designation by t
Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform23.4.2026 13:13:00 CEST | Press release
New structure to drive AI-powered innovation and international expansion Croma Pharma has launched a strategic joint venture to accelerate the development of Clinicore, its premium digital solution for aesthetic practices. This dedicated entity will focus on scaling the next generation of the platform while ensuring full continuity for existing users. Clinicore: Elevating Practice Excellence through AI Clinicore is a specialized SaaS (Software as a Service) solution designed to optimize the daily operations of aesthetic clinics. By automating patient management, scheduling, and administrative workflows, it enables healthcare professionals to focus entirely on patient care. A core element of the new strategy is a strong focus on Artificial Intelligence. Clinicore is evolving into a smart assistant, utilizing AI-driven features for automated treatment documentation, intelligent onboarding tools, and advanced process automation. This ensures that clinics can operate at maximum efficiency
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom